| Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study PP Piccaluga, F Fuligni, A De Leo, C Bertuzzi, M Rossi, F Bacci, ... Journal of Clinical Oncology 31 (24), 3019-3025, 2013 | 140 | 2013 |
| Nivolumab-induced cholangitic liver disease: a novel form of serious liver injury F Gelsomino, G Vitale, A D’Errico, C Bertuzzi, P Andreone, A Ardizzoni Annals of Oncology 28 (3), 671-672, 2017 | 93 | 2017 |
| Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature M Stanzani, M Cricca, C Sassi, E Sutto, G De Cicco, F Bonifazi, C Bertuzzi, ... Mycoses 62 (12), 1100-1107, 2019 | 19 | 2019 |
| First-line treatment of chronic myeloid leukemia with nilotinib: critical evaluation PP Piccaluga, S Paolini, C Bertuzzi, A De Leo, G Rosti Journal of Blood Medicine, 151-156, 2012 | 15 | 2012 |
| Clinical utility of measuring Epstein–Barr virus-specific cell-mediated immunity after HSCT in addition to virological monitoring: results from a prospective study A Chiereghin, G Piccirilli, T Belotti, A Prete, C Bertuzzi, D Gibertoni, ... Medical microbiology and immunology 208, 825-834, 2019 | 14 | 2019 |
| Physiological PTEN expression in peripheral T-cell lymphoma not otherwise specified A Gazzola, C Bertuzzi, C Agostinelli, S Righi, SA Pileri, PP Piccaluga Haematologica 94 (7), 1036, 2009 | 14 | 2009 |
| Lymph node core needle biopsy for the diagnosis of lymphoproliferative disorders: A word of caution. M Pizzi, C Agostinelli, L Santoro, M Sbaraglia, C Bertuzzi, L Dal Santo, ... European Journal of Haematology 106 (5), 2021 | 13 | 2021 |
| Immune microenvironment features and dynamics in Hodgkin lymphoma C Bertuzzi, E Sabattini, C Agostinelli Cancers 13 (14), 3634, 2021 | 11 | 2021 |
| Pityriasis lichenoides triggered by measles‐mumps‐rubella vaccine injection F Filippi, A Patrizi, E Sabattini, E Varotti, C Bertuzzi, A Pileri JDDG: Journal der Deutschen Dermatologischen Gesellschaft 18 (7), 758-760, 2020 | 11 | 2020 |
| Cutaneous adverse‐events in patients treated with ibrutinib A Pileri, A Guglielmo, C Agostinelli, V Evangelista, C Bertuzzi, ... Dermatologic Therapy 33 (6), e14190, 2020 | 10 | 2020 |
| BCL-2 expression in primary cutaneous follicle center B-cell lymphoma and its prognostic role A Pileri, C Agostinelli, C Bertuzzi, V Grandi, V Maio, I Lastrucci, ... Frontiers in Oncology 10, 662, 2020 | 9 | 2020 |
| Extracavitary primary effusion lymphoma in a post‐transplantation patient. M Zanelli, C Bertuzzi, M Zizzo, G Martino, E Sabattini, S Ascani British Journal of Haematology 187 (5), 2019 | 8 | 2019 |
| Progression in Ph-chromosome-negative myeloproliferative neoplasms: an overview on pathologic issues and molecular determinants E Sabattini, M Pizzi, C Agostinelli, C Bertuzzi, CA Sagramoso Sacchetti, ... Cancers 13 (21), 5531, 2021 | 7 | 2021 |
| Benign TdT-positive cells in pediatric and adult lymph nodes: a potential diagnostic pitfall M Pizzi, S Brignola, S Righi, C Agostinelli, C Bertuzzi, M Pillon, ... Human Pathology 81, 131-137, 2018 | 7 | 2018 |
| Successful management of EBV-PTLD in allogeneic bone marrow transplant recipient by virological–immunological monitoring of EBV infection, prompt diagnosis and early treatment A Chiereghin, C Bertuzzi, G Piccirilli, L Gabrielli, D Squarzoni, G Turello, ... Transplant Immunology 34, 60-64, 2016 | 7 | 2016 |
| Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation S Righi, D Novero, L Godio, C Bertuzzi, F Bacci, C Agostinelli, ... Human Pathology 124, 67-75, 2022 | 5 | 2022 |
| Role of chromatin assembly factor-1/p60 and poly [ADP-ribose] polymerase 1 in mycosis fungoides M Mascolo, A Travaglino, S Varricchio, D Russo, E Sabattini, C Agostinelli, ... Virchows Archiv 478, 961-968, 2021 | 5 | 2021 |
| Intrahepatocellular crystal storing mimicking a clinical liver disease during monoclonal gammopathy: report of a case and review of the literature M Riefolo, D Malvi, C Bertuzzi, E Sabattini, S Valente, G Pasquinelli, ... Ultrastructural Pathology 44 (1), 153-157, 2020 | 5 | 2020 |
| Erythroderma with brentuximab vedotin (skin side effects in mycosis fungoides) A Pileri, A Guglielmo, A Patrizi, B Casadei, C Bertuzzi, PL Zinzani, ... JDDG: Journal der Deutschen Dermatologischen Gesellschaft 19 (1), 99-102, 2021 | 4 | 2021 |
| TOX expression in mycosis fungoides and sezary syndrome A Pileri, M Cavicchi, C Bertuzzi, S Righi, C Zengarini, E Sabattini, ... Diagnostics 12 (7), 1582, 2022 | 3 | 2022 |
